rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-3-5
|
pubmed:databankReference |
|
pubmed:abstractText |
The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1538-3598
|
pubmed:author |
pubmed-author:AndersonGarnet LGL,
pubmed-author:AragakiAaronA,
pubmed-author:BeresfordShirley A ASA,
pubmed-author:BrzyskiRobertR,
pubmed-author:ChlebowskiRowan TRT,
pubmed-author:GassMargeryM,
pubmed-author:HeissGerardoG,
pubmed-author:LaCroixAndreaA,
pubmed-author:MansonJoAnn EJE,
pubmed-author:PrenticeRoss LRL,
pubmed-author:RossouwJacquesJ,
pubmed-author:StefanickMarcia LML,
pubmed-author:WHI Investigators,
pubmed-author:WallaceRobertR
|
pubmed:issnType |
Electronic
|
pubmed:day |
5
|
pubmed:volume |
299
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1036-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18319414-Aged,
pubmed-meshheading:18319414-Cardiovascular Diseases,
pubmed-meshheading:18319414-Estrogen Replacement Therapy,
pubmed-meshheading:18319414-Estrogens, Conjugated (USP),
pubmed-meshheading:18319414-Female,
pubmed-meshheading:18319414-Follow-Up Studies,
pubmed-meshheading:18319414-Humans,
pubmed-meshheading:18319414-Medroxyprogesterone Acetate,
pubmed-meshheading:18319414-Middle Aged,
pubmed-meshheading:18319414-Neoplasms,
pubmed-meshheading:18319414-Risk Assessment
|
pubmed:year |
2008
|
pubmed:articleTitle |
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
|
pubmed:affiliation |
University of North Carolina, School of Public Health, Department of Epidemiology, Chapel Hill, NC 27514-3628, USA. gerardo_heiss@unc.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|